Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study
Biomolecules · 13.03.2026 · 16 (3) · 423
DOI: 10.3390/biom16030423 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Biomolecules, online erschienen am 13.03.2026. Verfasst von Giorgio Facheris und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, ASST Spedali Civili and University of Brescia, 25100 Brescia, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Cytokines, Lung Neoplasms, Radiosurgery. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AIRC Italy Pre-Doc Fellowship.
Abstract (Originalsprache)
Introduction
Stereotactic radiotherapy (SRT) is increasingly used in oligometastatic non-small-cell lung cancer (NSCLC) and is known to elicit systemic immune effects, although the underlying mechanisms remain not fully understood.
Methods
In this prospective pilot study, we evaluated plasma cytokine variations in 19 patients with oligometastatic or oligoprogressive NSCLC undergoing SRT. Peripheral blood samples were collected before treatment (T0) and one month after SRT (T1) and the concentrations of nine cytokines (IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12p70, IL-17A and TNF-α) were quantified using a multiplex Luminex assay. Non-parametric tests and Cox regression models were used to investigate associations between cytokine levels, clinical variables, systemic treatments, and survival outcomes. SRT induced significant post-treatment increases in IFN-γ, IL-2, and IL-6, consistent with systemic pro-inflammatory activation and T-cell stimulation. Cytokine dynamics were influenced by patient- and tumor-related factors: female sex was associated with higher IL-2 and TNF-α levels; oncogene-addicted tumors showed lower IL-6 levels; and oligoprogressive disease exhibited attenuated cytokine variations compared with metachronous oligometastatic disease. Tyrosine kinase inhibitors were associated with globally reduced cytokine levels and blunted IL-1/IL-2 changes, whereas patients receiving immune checkpoint inhibitors displayed higher IL-2 and IL-6 concentrations and greater post-SRT increases in IFN-γ. Oncogene-addicted status and IL-12 variation emerged as independent predictors of overall survival and a composite model integrating these variables significantly stratified prognosis.
Conclusions
These findings suggest that SRT triggers measurable systemic immune activation in oligometastatic NSCLC, which is further shaped by tumor biology, disease burden, and concomitant systemic therapies. Although limited by the small sample size, this study supports the feasibility and potential utility of cytokine profiling to refine patient selection and guide biomarker-driven combinations of SRT with targeted and immune-based treatments, warranting validation in larger prospective cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, ASST Spedali Civili and University of Brescia, 25100 Brescia, Italy.
- Radiotherapy Unit, Department of Oncology and Hematology, Azienda Ospedaliero-Universitaria di Modena, 41100 Modena, Italy.
- Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41100 Modena, Italy.
- Department of Precision Medicine, University of Campania "l. Vanvitelli", 80100 Naples, Italy.
- Department of Molecular and Translational Medicine, University of Brescia, 25100 Brescia, Italy.
- Radiation Oncology Department, Bellaria Hospital, AUSL of Bologna, 40100 Bologna, Italy.
ORCID-Profile: Giorgio Facheris, Valerio Nardone, Lorenzo Granello, Anna Gogna, Luca Triggiani, Michela Buglione di Monale E Bastia, Giorgio Biasiotto, Roberto Bresciani, Paolo Borghetti
Förderung
- AIRC Italy Pre-Doc Fellowship
Zitieren
APA
Facheris, G., Bruni, A., Nardone, V., Guerini, A. E., Granello, L., Gogna, A., Triggiani, L., Buglione di Monale E Bastia, M., D'Angelo, E., Bettelli, S., Di Pressa, F., Colosini, A., Biasiotto, G., Bresciani, R., & Borghetti, P. (2026). Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study. Biomolecules, 16(3), 423. https://doi.org/10.3390/biom16030423
Vancouver
Facheris G, Bruni A, Nardone V, Guerini AE, Granello L, Gogna A, et al. Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study. Biomolecules. 2026;16(3):423. doi:10.3390/biom16030423
BibTeX
@article{Facheris2026,
author = {Facheris, Giorgio and Bruni, Alessio and Nardone, Valerio and Guerini, Andrea Emanuele and Granello, Lorenzo and Gogna, Anna and Triggiani, Luca and Buglione di Monale E Bastia, Michela and D'Angelo, Elisa and Bettelli, Stefania and Di Pressa, Francesca and Colosini, Antonella and Biasiotto, Giorgio and Bresciani, Roberto and Borghetti, Paolo},
title = {Role of Cytokines in Oligometastatic Non-Small-Cell Lung Cancer Treated with Stereotactic Radiation Therapy: An Observational Pilot Study},
journal = {Biomolecules},
year = {2026},
volume = {16},
number = {3},
pages = {423},
doi = {10.3390/biom16030423}
}
EUVIMED